115
Participants
Start Date
September 20, 2021
Primary Completion Date
December 14, 2024
Study Completion Date
December 23, 2024
DFV890
DFV890
Placebo
Placebo
Novartis Investigative Site, Budapest
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Kecskemét
Novartis Investigative Site, Veszprém
Novartis Investigative Site, Berlin
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Bad Doberan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Ctr for Adv Research and Education, Gainesville
Conquest Research, Winter Park
IRIS Research and Development, Plantation
Novartis Investigative Site, Seville
Northwestern University, Chicago
Novartis Investigative Site, Brno
Skylight Health Res Inc Color Spr, Colorado Springs
ARENSIA Explor Med Res Clinic, Phoenix
Novartis Investigative Site, Nové Mesto nad Váhom
TriWest Reserach Associates, El Cajon
Novartis Investigative Site, Piešťany
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, CABA
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Nový Jičín
Novartis Investigative Site, Prague
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Miskolc
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY